Your browser is no longer supported. Please, upgrade your browser.
RPRX Repros Therapeutics Inc. monthly Stock Chart
RPRX [NASD]
Repros Therapeutics Inc.
Index- P/E- EPS (ttm)-1.37 Insider Own3.63% Shs Outstand24.28M Perf Week-3.64%
Market Cap173.60M Forward P/E- EPS next Y-1.11 Insider Trans0.00% Shs Float24.17M Perf Month1.71%
Income-32.50M PEG- EPS next Q-0.26 Inst Own65.30% Short Float14.10% Perf Quarter-16.76%
Sales- P/S- EPS this Y-1.50% Inst Trans-3.41% Short Ratio9.53 Perf Half Y-26.29%
Book/sh1.50 P/B4.77 EPS next Y21.30% ROA-63.00% Target Price28.20 Perf Year-58.67%
Cash/sh1.56 P/C4.58 EPS next 5Y- ROE-66.80% 52W Range5.92 - 22.55 Perf YTD-28.28%
Dividend- P/FCF- EPS past 5Y26.00% ROI- 52W High-68.29% Beta0.56
Dividend %- Quick Ratio19.20 Sales past 5Y- Gross Margin- 52W Low20.78% ATR0.26
Employees26 Current Ratio19.20 Sales Q/Q- Oper. Margin- RSI (14)42.82 Volatility3.63% 3.57%
OptionableYes Debt/Eq0.00 EPS Q/Q7.90% Profit Margin- Rel Volume0.48 Prev Close7.09
ShortableYes LT Debt/Eq0.00 EarningsAug 10 BMO Payout- Avg Volume357.85K Price7.15
Recom1.60 SMA20-1.83% SMA50-5.37% SMA200-16.70% Volume172,811 Change0.85%
May-14-13Reiterated Ascendiant Capital Markets Strong Buy $19 → $23
Mar-28-13Reiterated Ladenburg Thalmann Buy $18 → $25
Nov-15-12Reiterated Ascendiant Capital Markets Strong Buy $12 → $18
Oct-09-12Reiterated Ladenburg Thalmann Buy $15 → $18
Apr-10-12Initiated Ascendiant Capital Markets Strong Buy $6
Mar-16-11Reiterated Ladenburg Thalmann Buy $6 → $9
Jun-18-15 02:31PM  3 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Jun-09-15 04:40PM  Repros' Enclomiphene to Face FDA Advisory Panel in November - Analyst Blog
06:03AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
Jun-08-15 05:48PM  Repros Announces Date of FDA Advisory Committee Review of NDA GlobeNewswire
Jun-01-15 04:17PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-15-15 01:04PM  REPROS THERAPEUTICS INC. Financials
May-10-15 08:11PM  10-Q for Repros Therapeutics, Inc. at Company Spotlight
May-08-15 04:03PM  Repros Reports Narrower Y/Y Loss in Q1, Pipeline in Focus - Analyst Blog
May-07-15 04:15PM  What's in Store for Repros (RPRX) this Earnings Season? - Analyst Blog
11:18AM  Repros Therapeutics reports 1Q loss
09:16AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition
09:15AM  Repros Therapeutics Inc.(R) Reports First Quarter 2015 Financial Results GlobeNewswire
May-04-15 08:12PM  10-K for Repros Therapeutics, Inc. at Company Spotlight
Apr-15-15 05:24PM  Repros Announces November 30, 2015 PDUFA Goal Date for New Drug Application at noodls
04:03PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
04:01PM  Repros Announces November 30, 2015 PDUFA Goal Date for New Drug Application GlobeNewswire
Apr-13-15 01:27PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
Apr-08-15 08:56AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
Apr-07-15 02:50PM  Repros Gets EU Update on Secondary Hypogonadism Drug - Analyst Blog
Apr-06-15 04:20PM  Repros Receives Confirmation of Eligibility for Submission of a Centralized Marketing Authorization Application to the European Medicines Agency as a New Active Substance at noodls -5.07%
04:02PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
04:01PM  Repros Receives Confirmation of Eligibility for Submission of a Centralized Marketing Authorization Application to the European Medicines Agency as a New Active Substance GlobeNewswire
Apr-02-15 05:24PM  Repros' Secondary Hypogonadism Drug Under FDA Review - Analyst Blog
04:27PM  Lumber Liquidators, CarMax are big market movers
Apr-01-15 05:06PM  Repros shares rally on testicle-stimulation drug application at MarketWatch
04:36PM  Repros Announces Acceptance for Filing of NDA at noodls
04:02PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
04:01PM  Repros Announces Acceptance for Filing of NDA GlobeNewswire
Mar-16-15 10:33AM  Repros (RPRX) Incurs Narrower-than-Expected Loss in Q4 - Tale of the Tape
10:11AM  Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results at noodls
09:48AM  Repros Therapeutics reports 4Q loss
09:17AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition
09:15AM  Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results GlobeNewswire
Mar-11-15 05:58PM  Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog
Feb-26-15 01:18PM  5 Stocks Under $10 to Trade for Breakouts: SouFun, Repros and More at TheStreet
Feb-10-15 04:49PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-03-15 06:15PM  Repros Files for Androxal in the U.S. for Hypogonadism - Analyst Blog
Feb-02-15 09:32AM  Repros Submits New Drug Application to FDA for Androxal (R) at noodls
09:16AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
09:15AM  Repros Submits New Drug Application to FDA for Androxal (R) GlobeNewswire
Jan-12-15 09:02AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
Dec-29-14 04:44PM  Repros Initiates Two Phase 2B Uterine Fibroid Studies at noodls +6.71%
04:25PM  Energy Spinoffs Transocean Partners, Seventy Seven Energy Tumble at TheStreet
04:19PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04:15PM  Repros Updates Androxal(R) Global Regulatory Status GlobeNewswire
04:15PM  Repros Initiates Two Phase 2B Uterine Fibroid Studies GlobeNewswire
09:15AM  Court Rules Inventors Correctly Named on Androxal(R) Patents GlobeNewswire
Dec-08-14 04:54PM  How To Profit From The Obesity Epidemic Benzinga
Nov-12-14 07:09PM  10-Q for Repros Therapeutics, Inc. Company Spotlight
Nov-11-14 10:28AM  Brean Capital Sees No Surprises In 3Q14 Report For Repros Therapeutics Benzinga
Nov-10-14 04:20PM  Repros Soars on Positive FDA Meeting Regarding Androxa Zacks -8.89%
09:13AM  Repros Therapeutics posts 3Q loss AP
09:00AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
09:00AM  Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q3 2014 Repros Therapeutics Inc Earnings Release - Before Market Open CCBN
Nov-07-14 04:28PM  Another lackluster session for major equities Yahoo Finance Blogs +56.90%
03:42PM  Sears Soars Nearly +40% As REIT News Boosts Confidence at TheStreet
11:07AM  Repros Therapeutics (RPRX) Stock Skyrockets After Meeting with FDA About Androxal at TheStreet
Nov-06-14 04:27PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events EDGAR Online
04:15PM  Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing GlobeNewswire
Nov-05-14 02:12PM  Will Repros (RPRX) Miss Estimates This Earnings Season? Zacks
Oct-31-14 08:38AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online -6.07%
Oct-27-14 04:02PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04:01PM  Repros to Webcast Investor and Analyst Day on October 31st GlobeNewswire
Oct-21-14 04:02PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04:01PM  Results From Long-Term Study of Androxal(R) Exhibit Positive Safety Profile GlobeNewswire
Oct-20-14 01:33PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Repros Therapeutics Inc. - RPRX PR Newswire
10:36AM  INVESTOR ALERT: Investigation of Repros Therapeutics Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
09:00AM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics Inc. PR Newswire
Oct-17-14 08:28PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Repros Therapeutics Inc. (RPRX) To Contact The Firm PR Newswire -39.96%
03:17PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Repros Therapeutics Inc. - RPRX Business Wire
12:11PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros Therapeutics, Inc. - RPRX PR Newswire
09:26AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09:15AM  Repros Therapeutics shares drop on drug application setback at MarketWatch
08:57AM  [$$] Repros Therapeutics Shares Drop Premarket at The Wall Street Journal
Oct-16-14 08:01PM  Upcoming FDA Meeting to be Type C Meeting GlobeNewswire
Sep-29-14 01:10PM  Can Repros Therapeutics Shares Still More Than Double? at 24/7 Wall St.
08:00AM  Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% Zacks
Sep-26-14 02:16PM  5 Breakout Stocks Under $10 Set to Soar at TheStreet +16.96%
01:17PM  Nasdaq stocks posting largest percentage increases AP
08:43AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
06:45AM  FDA Schedules Type B Pre-NDA Meeting With Repros GlobeNewswire
Sep-25-14 08:20PM  Androxal(R) Second Pivotal Study Achieves Superiority in Top Line Analysis for Both Co-Primary Endpoints Versus Marketed Topical Gel in the Treatment of Secondary Hypogonadism GlobeNewswire
Sep-22-14 04:37PM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
02:13PM  Nasdaq stocks posting largest percentage decreases AP
10:14AM  [$$] FDA Recommendation Doesn't Apply to Androxal, Repros Says at The Wall Street Journal
09:15AM  Repros Gives Update on Androxal(R) With Respect to Recent FDA Advisory Panel Outcome and Announces Upcoming Presentation at Biocentury GlobeNewswire
Sep-18-14 01:04PM  Rite Aid Plunges As Full-Year Outlook Dims at TheStreet -21.66%
12:34PM  Why Repros Therapeutics (RPRX) Stock Plummeted to a One-Year Low Today at TheStreet
07:06AM  Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% Zacks
Sep-05-14 02:49PM  Infoblox Inc. (BLOX) Climbs On Earnings at TheStreet
12:36PM  Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline Benzinga
Aug-28-14 03:30PM  Repros Reports Encouraging Late-Stage Data on Androxal Zacks +18.51%
01:11PM  Williams-Sonoma Stumbles After Yesterday's Surge at TheStreet
11:15AM  Markets Open Lower; Dollar General Profit Matches Street View Benzinga
10:00AM  Why Repros Therapeutics (RPRX) Stock Is Surging Today at TheStreet
08:35AM  REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Aug-27-14 09:46PM  Repros says its testosterone drug found superior in study Reuters
08:10PM  Androxal(R) Achieves Superiority in Top Line Analysis for Both Co-Primary Endpoints and Various Secondary Endpoints Versus Marketed Topical Gel in First of Two Identical Studies in the Treatment of Secondary Hypogonadism GlobeNewswire
Aug-22-14 06:47AM  Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% Zacks +11.76%
Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States. Its product portfolio includes Androxal, an oral therapy, which is in Phase III clinical trials for the treatment of low testosterone due to secondary hypogonadism; and Proellex that is in Phase IIB clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis. The company has a license agreement with the National Institutes of Health to develop and commercialize Proellex. Repros Therapeutics Inc. was founded in 1987 and is based in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson KatherineChief Financial OfficerNov 12Buy9.413,50032,95211,875Nov 12 05:19 PM
PODOLSKI JOSEPHPresident and CEONov 12Buy9.424,70044,27465,745Nov 12 05:17 PM
Masterson Nola EDirectorSep 15Buy14.342002,8683,305Sep 17 09:43 AM
PODOLSKI JOSEPHPresident and CEOAug 14Buy13.912,10029,21161,045Aug 14 03:53 PM
Anderson KatherineChief Financial OfficerAug 14Buy13.852,00027,7008,375Aug 14 03:51 PM